Inventor · disambiguated record
Wayne R. Kindsvogel
Also filed as: KINDSVOGEL WAYNE · KINDSVOGEL WAYNE R
104 granted patents·95 pending applications·2,384 citations·filing 1987–2020
99Inventor score
Top patents by PatentIndex Score
199 records- 0199US9499855B2Compositions, methods, and computer systems related to making and administering modified T cellsELWHA LLC·Filed 2013·Granted Nov 22, 2016·108 cites·12 claims
- 0298US7038032B2Cytokine protein familyZYMOGENETICS INC·Filed 2002·Granted May 2, 2006·101 cites·20 claims
- 0398US6323323B1Ligand-binding, dimerized polypeptide fusionsZYMOGENETICS INC·Filed 1999·Granted Nov 27, 2001·196 cites·10 claims
- 0498US6300099B1Methods for producing secreted ligand-binding fusion proteinsZYMOGENETICS INC·Filed 2000·Granted Oct 9, 2001·129 cites·9 claims
- 0598US6291212B1DNA constructs encoding ligand-binding fusion proteinsZYMOGENETICS INC·Filed 2000·Granted Sep 18, 2001·134 cites·6 claims
- 0698US6291646B1Dimerized polypeptide fusionsZYMOGENETICS INC·Filed 2000·Granted Sep 18, 2001·146 cites·5 claims
- 0797US7135170B2Methods for treating viral infection using IL-28 and IL-29ZYMOGENETICS INC·Filed 2003·Granted Nov 14, 2006·97 cites·5 claims
- 0897US6018026ABiologically active dimerized and multimerized polypeptide fusionsZYMOGENETICS INC·Filed 1997·Granted Jan 25, 2000·148 cites·29 claims
- 0996US7959908B2Methods of treating viral infections using IL-21ZYMOGENETICS INC·Filed 2009·Granted Jun 14, 2011·22 cites·6 claims
- 1096US7351689B2Use of IL-28 and IL-29 to treat cancer and autoimmune disordersZYMOGENETICS INC·Filed 2005·Granted Apr 1, 2008·68 cites·6 claims
- 1196US5843725AMethods of producing secreted receptor analogs and biologically active dimerized polypeptide fusionsZYMOGENETICS INC·Filed 1995·Granted Dec 1, 1998·179 cites·49 claims
- 1295US7485699B2Cytokine protein familyZYMOGENETICS INC·Filed 2006·Granted Feb 3, 2009·20 cites·11 claims
- 1395US7462467B2Cytokine protein familyZYMOGENETICS INC·Filed 2006·Granted Dec 9, 2008·20 cites·20 claims
- 1495US7455993B2Cytokine protein familyZYMOGENETICS INC·Filed 2006·Granted Nov 25, 2008·20 cites·22 claims
- 1595US7445773B2Cytokine protein familyZYMOGENETICS INC·Filed 2006·Granted Nov 4, 2008·20 cites·20 claims
- 1695US7446172B2Cytokine protein familyZYMOGENETICS INC·Filed 2006·Granted Nov 4, 2008·20 cites·23 claims
- 1795US6897292B2Human cytokine receptorZYMOGENETICS INC·Filed 2000·Granted May 24, 2005·51 cites·27 claims
- 1894US9587237B2Compositions, methods, and computer systems related to making and administering modified T cellsELWHA LLC·Filed 2013·Granted Mar 7, 2017·15 cites·5 claims
- 1994US5567584AMethods of using biologically active dimerized polypeptide fusions to detect PDGFZYMOGENETICS INC·Filed 1994·Granted Oct 22, 1996·122 cites·5 claims
- 2094US5155027AMethod of producing secreted receptor analogs and biologically active peptide dimersZYMOGENETICS INC·Filed 1989·Granted Oct 13, 1992·211 cites·1 claims
- 2193US9662354B2Compositions, methods, and computer systems related to making and administering modified T cellsELWHA LLC·Filed 2016·Granted May 30, 2017·5 cites·4 claims
- 2293US7655222B2Method of using interferon-like protein ZCYTO20 (IL-28A) or ZCYTO22 (IL-28B) to treat hepatitis CZYMOGENETICS LLC·Filed 2007·Granted Feb 2, 2010·12 cites·16 claims
- 2393US7537761B2Anti-IL-22RA antibodies and binding partners and methods of using in inflammationZYMOGENETICS INC·Filed 2005·Granted May 26, 2009·18 cites·19 claims
- 2492US7662927B2Antibodies to ZCYTO20 (IL-28A) and ZCYTO22 (IL-28B)ZYMOGENETICS LLC·Filed 2008·Granted Feb 16, 2010·10 cites·13 claims
- 2591US9175072B2Compositions and methods including recombinant B lymphocyte cell line including an exogenously incorporated nucleic acid expressing an exogenous membrane immunoglobulin reactive to a first antigen and including an endogenous gene expressing an endogenous secreted immunoglobulin reactive to a second antigenHYDE RODERICK A·Filed 2011·Granted Nov 3, 2015·7 cites·38 claims
- 2691US7829076B2Method of using interferon-like potein ZCYTO20 (IL-28A) or ZCYTO22(IL-28B) to treat hepatitis BZYMOGENETICS LLC·Filed 2009·Granted Nov 9, 2010·8 cites·16 claims
- 2791US7638602B2Human cytokine receptorZYMOGENETICS INC·Filed 2007·Granted Dec 29, 2009·11 cites·3 claims
- 2890US7351555B2Mouse cytokine receptor Zcytor16ZYMOGENETICS INC·Filed 2005·Granted Apr 1, 2008·13 cites·33 claims
- 2990US7265203B2Human cytokine receptorZYMOGENETICS INC·Filed 2004·Granted Sep 4, 2007·24 cites·11 claims
- 3089US8058872B2Systems, devices, methods, and compositions including functionalized ferromagnetic structuresHYDE RODERICK A·Filed 2009·Granted Nov 15, 2011·5 cites·20 claims
- 3189US7189839B2Isolated polynucleotides encoding a human cytokine receptor human cytokine receptorZYMOGENETICS INC·Filed 2004·Granted Mar 13, 2007·19 cites·32 claims
- 3289US6875845B2Mouse cytokine receptorZYMOGENETICS INC·Filed 2002·Granted Apr 5, 2005·28 cites·19 claims
- 3389US5750375AMethods of producing secreted receptor analogs and biologically active dimerized polypeptide fusionsZYMOGENETICS INC·Filed 1995·Granted May 12, 1998·95 cites·9 claims
- 3488US10745468B2Compositions and methods for modified B cells expressing reassigned biological agentsKOTA BIOTHERAPEUTICS LLC·Filed 2018·Granted Aug 18, 2020·3 cites·48 claims
- 3588US7491809B2Polynucleotides encoding human cytokine receptorZYMOGENETICS INC·Filed 2006·Granted Feb 17, 2009·6 cites·34 claims
- 3688US7393684B2Immunoconjugates of anti-IL-20 antibodies and hybridoma cell lines expressing anti-IL-20 antibodiesZYMOGENETICS INC·Filed 2004·Granted Jul 1, 2008·25 cites·24 claims
- 3787US7615611B2Human cytokine receptorZYMOGENETICS INC·Filed 2007·Granted Nov 10, 2009·5 cites·12 claims
- 3886US10597442B2Compositions and methods for modified B cells expressing reassigned biological agentsKOTA BIOTHERAPEUTICS LLC·Filed 2019·Granted Mar 24, 2020·2 cites·13 claims
- 3986US7786075B2Use of IL-28 and IL-29 to treat cancer and autoimmune disordersZYMOGENETICS LLC·Filed 2008·Granted Aug 31, 2010·7 cites·12 claims
- 4085US5770445AGlucagon receptor proteins, peptides, and antibodiesZYMOGENETICS INC·Filed 1995·Granted Jun 23, 1998·47 cites·18 claims
- 4184US10233424B2Compositions and methods including cytotoxic B lymphocyte cell line expressing exogenous membrane immunoglobulin different from secreted immunoglobulinELWHA LLC·Filed 2016·Granted Mar 19, 2019·2 cites·18 claims
- 4284US8283448B2Methods for treating viral infection using IL-28 and IL-29 cysteine mutantsKLUCHER KEVIN M·Filed 2011·Granted Oct 9, 2012·5 cites·12 claims
- 4384US8124077B2Anti-IL-TIF antibodies and methods of makingPRESNELL SCOTT R·Filed 2009·Granted Feb 28, 2012·4 cites·9 claims
- 4484US7045498B2Soluble Zcytor11 cytokine receptorsZYMOGENETICS INC·Filed 2001·Granted May 16, 2006·14 cites·9 claims
- 4583US9512213B2Compositions and methods including recombinant B lymphocyte cell line including an exogenously incorporated nucleic acid expressing an exogenous membrane immunoglobulin reactive to a first antigen and including an endogenous gene expressing an endogenous secreted immunoglobulin reactive to a second antigenELWHA LLC·Filed 2014·Granted Dec 6, 2016·2 cites·17 claims
- 4682US9286615B2Devices and methods for recording information on a subject's bodyHYDE RODERICK A·Filed 2011·Granted Mar 15, 2016·4 cites·45 claims
- 4781US10667742B2Systems, devices and methods for monitoring breastfeedingELWHA LLC·Filed 2017·Granted Jun 2, 2020·3 cites·23 claims
- 4881US8124088B2Methods of treatment using anti-IL-22RA antibodiesXU WENFENG·Filed 2009·Granted Feb 28, 2012·3 cites·4 claims
- 4981US8106655B2Multiplex imaging systems, devices, methods, and compositions including ferromagnetic structuresHYDE RODERICK A·Filed 2009·Granted Jan 31, 2012·9 cites·20 claims
- 5080US9681615B2Rapid breeding of plantsELWHA LLC·Filed 2013·Granted Jun 20, 2017·1 cites·17 claims
Showing the top 50 of 199 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Wayne R. Kindsvogel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →